Epigenomics AG Long Term Debt

Epigenomics AG posts a long-term debt of $11M as of June 2026. That compares with $11M in the prior-year period — up 0.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Epigenomics AG's long-term debt was $11M. The latest reading is $11M — essentially flat versus a year earlier (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Long-Term Debt is one piece of Epigenomics AG's financial statement story. At $11M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for EPGNF's long-term debt usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Epigenomics AG's other metric pages and overview cover the third.